Danielle Kirsh

Johnson & Johnson announced it will invest more than $55 billion in its U.S. pharma and medtech operations over the next four years.

BVI Medical today announced it completed a $1 billion strategic capital raise in partnership with asset management firm TPG.

Phantom Neuro received FDA breakthrough device designation and TAP designation for its minimally invasive neural interface Phantom X.

Flosonics Medical secured $7.5 million CAD ($5.2 million USD) in venture debt financing from RBCx to accelerate market adoption of its FloPatch wireless wearable ultrasound technology.

Thermo Fisher Scientific plans to acquire Solventum's Purification and Filtration business for $4.1 billion in cash.

Neurovalens said its Modius Sleep insomnia treatment will be available to veterans through a U.S. Department of Veterans Affairs program.

The FDA is attempting to rehire some of the employees it recently dismissed, according to Reuters.

Biotronik and Egg Medical are partnering to improve radiation protection for interventional healthcare workers.

Accelus this week announced its FlareHawk Interbody Fusion System received regulatory approval in Brazil.

Plexāā recently announced a new partnership with Panasonic Manufacturing UK as their contract manufacturer for the Bloom device.

MassMEDIC will host its annual Medtech Impact Symposium and Gala on March 6, 2025, bringing together more than 600 industry stakeholders.

President Donald Trump has swiftly announced a series of executive orders that could impact the medech industry.

TransMedics is facing allegations of fraud, organ trafficking, and unethical practices that have triggered shareholder investigations.

BD today announced it appointed Pamela Spikner as senior VP, chief accounting officer, and controller, effective January 20.

Avinger announced this week it laid off 36 employees as part of a corporate restructuring to focus on new technology.

Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities.

CMS announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries.

Johnson & Johnson today announced the FDA has expanded its approval of Impella heart pumps to treat specific pediatric patients.

Theradaptive announced this week that it received FDA approval to expand its clinical trial for OsteoAdapt SP.

Artivion this week announced it received FDA humanitarian device exemption (HDE) for its AMDS Hybrid Prosthesis.